112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
Diagnostic, Prognostic and Therapeutic Uses of MIRs in Adaptive Pathways and/or Disease Pathways
#1802Methylation Profile of Cancer
#1803MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21
#1804Biomarkers for Diagnosis and Treatment of Chronic Lymphocytic Leukemia
#1805MARKER GENES BASED ON AMIODARONE TREATMENT FOR SCREENING OF DRUG INDUCING PULMONARY TOXICITY AND SCREENING METHODS USING THE SAME
#1806Micrornas and uses thereof
#1807Methods for detection of the oncogenic T1796A B-Raf mutation
#1808Circulating Tumor and Tumor Stem Cell Detection Using Genomic Specific Probes
#1809METHODS OF AIDING IN THE DIAGNOSIS OF PROSTATE CANCER
#1810CISD2-Knockout Mice and Uses Thereof
#1811G PROTEIN COUPLED RECEPTORS AND USES THEREOF
#1812METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS
#1813Method to Predict Responsiveness of Breast Cancer to Polyamine-Type Chemotherapy
#1814Genome Wide Visual Identification of Human Co-Factors of HIV-1 Infection
#1815Methods for reverting methylation by targeting methyltransferases
#1816GENE EXPRESSION PROFILE THAT PREDICTS OVARIAN CANCER SUBJECT RESPONSE TO CHEMOTHERAPY
#1817METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR
#1818METHODS FOR PREDICTING OR MONITORING WHETHER A PATIENT AFFECTED BY A CANCER IS RESPONSIVE TO A TREATMENT WITH A MOLECULE OF THE TAXOID FAMILY
#1819MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P
#1820Methods and compositions using splicing regulatory proteins involved in tumor suppression
#1821METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE
#1822DNA methylation analysis of regulatory T cells through DNA-methylation analysis of the TSDR region of the gene FOXP3
#1823IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#1824USE OF GPR151 MODULATORS FOR THE TREATMENT OF PAIN
#1825IVIG MODULATION OF CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE
#1826PSA AND KLK2 AS THERAPEUTIC TARGETS AND MOLECULES INHIBITING PSA AND KLK2
#1827RAS RESPONSIVE ELEMENT BINDING PROTEIN 1 (RREB1) AS A THERAPEUTIC TARGET FOR THALASSEMIAS AND SICKLE CELL ANEMIA
#1828MOLECULAR MARKERS FOR CANCER PROGNOSIS
#1829TARGETS, METHODS, AND REAGENTS FOR DIAGNOSIS AND TREATMENT OF SCHIZOPHRENIA
#1830MICRORNA EXPRESSION PROFILE ASSOCIATED WITH PANCREATIC CANCER
#1831Methods of diagnosing endometriosis
#1832ALGORITHMS FOR OUTCOME PREDICTION IN PATIENTS WITH NODE-POSITIVE CHEMOTHERAPY-TREATED BREAST CANCER
#1833miRNAs as therapeutic targets in cancer
#1834Diagnosis/Therapeutic Strategy For Gynecological Cancer by Utilizing Micro-RNA as Biomarker
#1835Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer
#1836DIAGNOSIS OF PROSTATE CANCER
#1837Alternatively Transcribed Genes Associated with Memory Consolidation
#1838CIDEA MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1839PRMT1 for target genes of cancer therapy and diagnosis
#1840OIP5 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS
#1841CANCER-RELATED GENES, CDCA5, EPHA7, STK31 AND WDHD1
#1842Methods and nucleic acids for analyses of cell proliferative disorders
#1843Method for the diagnosis of the presence of an ovarian cancer
#1844USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER
#1845USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER
#1846USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER
#1847MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA
#1848Methods for Screening for Antibiotic Compounds
#1849Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives
#1850DISORDERS OF VASOREGULATION AND METHODS OF DIAGNOSING THEM
#1851Automated high-content live animal drug screening using
#1852Method for predicting and detecting tumor metastasis
#1853CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer
#1854Compositions for the Detection and Treatment of Colorectal Cancer
#1855BIOMARKERS FOR ASSESSING RESPONSE TO C-MET TREATMENT
#1856INTERFERON EPSILON (IFNE1) AS A MARKER FOR TARGETED CANCER THERAPY
#1857USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER
#1858TEST METHOD FOR TYPE-2 DIABETES USING GENE POLYMORPHISM
#1859Fish-ribosyn for antibiotic susceptibility testing
#1860Gene expression markers of tumor resistance to HER2 inhibitor treatment
#1861GENOMIC APPROACHES TO FETAL TREATMENT AND DIAGNOSIS
#1862SCREENING FOR MODULATORS OF CES1 AND/OR CES3 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1863MODULATORS OF CARNITINE OCTANOYLTRANSFERASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1864COMPOSITIONS AND METHODS FOR DETERMINING THE PROGNOSIS OF BLADDER UROTHELIAL CANCER
#1865Diagnosis/treatment option for head-and-neck tumor using micro-RNA as biomarker
#1866System and method for high resolution analysis of nucleic acids to detect sequence variations
#1867METHODS AND REAGENTS FOR PREDICTING CLINICAL OUTCOME AND CUSTOMIZING CHEMOTHERAPY IN LUNG CANCER PATIENTS
#1868Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug
#1869Compositions and Methods for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
#1870Methods for Altering MRNA Splicing and Treating Familial Dysautonomia and Other Mechanistically Related Disorders
#1871Alternatively Transcribed Genes Associated with Schizophrenia
#1872METHOD FOR DETERMINING A PREDISPOSITION TO BASAL CELL CARCINOMA AND FOR SCREENING TREATMENTS THEREOF
#1873Oncogene NRF2
#1874MDA-7 PROTEINS AND METHODS OF USE THEREOF
#1875AIMP2-DX2 gene and its uses
#1876Prostate cancer related gene STYK1
#1877Anti-Tumor Cell Antigen Antibody Therapeutics
#1878Methods of identifying anti-cancer agents and uses thereof
#1879Polymorphisms associated with Parkinson's disease
#1880THERAPEUTIC AGENT AND TEST AGENT FOR DISEASE WITH MYOCARDIAL NECROSIS
#1881MULTI-GENE CLASSIFIERS AND PROGNOSTIC INDICATORS FOR CANCERS
#1882CYANOBACTERIA SAXITOXIN GENE CLUSTER AND DETECTION OF CYANOTOXIC ORGANISMS
#1883METHOD FOR DETERMINATION OF INFLAMMATORY DISEASE BY USING SINGLE NUCLEOTIDE POLYMORPHISM IN BRCA1-RELATED PROTEIN (BRAP) GENE
#1884METHODS FOR CONTROLLING VASCULOGENESIS
#1885Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)
#1886Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy
#1887Molecular diagnosis and classification of malignant melanoma
#1888Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
#1889METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#1890Method of screening compounds using CALHM (FAM26C)
#1891IDENTIFICATION OF A MOLECULAR SIGNATURE FOR ANTIPSYCHOTICS AND SERMS
#1892MARKER GENES FOR SCREENING OF DRUG-INDUCED TOXICITY IN HUMAN CELLS AND SCREENING METHOD USING THE SAME
#1893Antibody Specific to the AIMP2-DX2
#1894MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES
#1895SIRT1 POLYMORPHIC VARIANTS AND METHODS OF USE THEREOF
#1896Methods for enhancing muscle performance and tone
#1897Method of performing one-step, single cell RT-PCR
#1898Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms
#1899Assays for agents affecting megakaryocyte development
#1900Copy Number Variations Predictive of Risk of Schizophrenia
#1901METHODS AND KITS FOR MONITORING THE EFFECTS OF IMMUNOMODULATORS ON ADAPTIVE IMMUNITY
#1902METHOD FOR ANALYSING THE EPIGENETIC STATUS OF THE HTRA 1 GENE IN A BIOLOGICAL SAMPLE
#1903Novel genes and markers in type 2 diabetes and obesity
#1904Novel genes and markers in type 2 diabetes and obesity
#1905BIOMARKERS FOR MONITORING THE TREATMENT BY QUINAZOLINONE COMPOUNDS
#1906CTGF AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
#1907Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants
#1908Compositions and Methods for the Treatment and Diagnosis of Cancer
#1909Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
#1910SKIN CANCER ASSOCIATED MICRORNAS
#1911Methods of using MIR34 as a biomarker for TP53 functional status
#1912PRO-EPIL EXPRESSION LEVEL IN A BIOLOGICAL SAMPLE AS TESTICULAR CANCER BIOMARKER, PARTICULARLY IN COMBINATION WITH THE HCBETA AND AFP BIOMARKERS
#1913NOVEL KINASES AND USES THEREOF
#1914RECURRENT GENE FUSIONS IN LUNG CANCER
#1915SNP DETECTION AND OTHER METHODS FOR CHARACTERIZING AND TREATING BIPOLAR DISORDER AND OTHER AILMENTS
#1916NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY
#1917INSULIN RESISTANCE MARKER
#1918Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV
#1919Compositions and methods for the identification, assessment, prevention and therapy of human cancers
#1920Natural killer p30 (NKp30) dysfunction and the biological applications thereof
#1921Methods of treating pre-malignant ductal cancer with autophagy inhibitors
#1922Membrane Associated Tumor Endothelium Markers
#1923USE OF ID4 FOR DIAGNOSIS AND TREATMENT OF CANCER
#1924IN VITRO METHODS FOR DETECTING RENAL CANCER
#1925SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS
#1926Method of judging inflammatory disease by using single nucleotide polymorphism
#1927Modulation of growth hormone receptor expression and insulin-like growth factor expression
#1928COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMA
#1929ASSESSMENT OF EFFECT OF AN AGENT ON A HUMAN BIOLOGICAL CONDITION USING RODENT GENE EXPRESSION PANELS
#1930Methods for the diagnosis and treatment of lung cancer
#1931Cathepsin C-based screening methods for identifying modulators of pain
#1932EXPRESSION OF KIR IN HUMAN CANCER CELLS AS A BIOMARKER FOR IMMUNO-ESCAPE AND CANCER METASTASIS
#1933Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases
#1934GABA biomarkers for depression
#1935Methods for treating spinal muscular atrophy
#1936IN VITRO METHOD FOR DIAGNOSING SKIN CANCER
#1937Method for detection of idiopathic interstitial pneumonia
#1938DKAT CELL LINE, A MODEL FOR HUMAN TRIPLE-NEGATIVE BREAST CANCER
#1939Gene overexpressed in cancer
#1940MARKERS AND METHODS RELATING TO THE ASSESSMENT OF ALZHEIMER'S DISEASE
#1941Methods for Screening for Anti-Graying Agents on the Basis of AFF-4
#1942METHOD FOR PREDICTING AND DIAGNOSING BRAIN TUMOR
#1943DKK1 oncogene as therapeutic target for cancer and a diagnosing marker
#1944MATERIALS AND METHODS RELATING TO A G-PROTEIN COUPLED RECEPTOR
#1945Novel tumor marker determination
#1946Phage microarray profiling of the humoral response to disease
#1947IMP-1 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG CANCER
#1948mutations in melanoma
#1949MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER
#1950Recurrent gene fusions in prostate cancer
#1951OSTEOARTHRITIS-SENSITIVE GENE
#1952Transcription biomarkers of biological responses and methods
#1953METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
#1954MEDICAMENT, COMPOSITIONS, AND SUBSTANCES FOR TREATING AND IDENTIFYING ADENOCARCINOMA OF THE LUNG
#1955METHOD OF MODULATING ANGIOGENESIS
#1956Modulators of alpha-synuclein toxicity
#1957GLUTAMINE BIOMARKERS FOR DEPRESSION
#1958BIOMARKERS FOR DEPRESSION
#1959Diagnosing and treating hormone resistant cancers
#1960Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein
#1961P13K pathway mutations in cancer
#1962GAB2 AMPLIFICATION IN MELANOMA
#1963PAKs as Modifiers of the CHK Pathway and Methods of Use
#1964MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
#1965Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
#1966Methods for determining cancer resistance to histone deacetylase inhibitors
#1967METHOD TO PROGNOSE RESPONSE TO ANTI-EGFR THERAPEUTICS
#1968MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof
#1969METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
#1970METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING LUPUS
#1971Identification of novel subgroups of high-risk pediatric precursor B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same
#1972CANDIDATE GENES AND BLOOD BIOMARKERS FOR BIPOLAR MOOD DISORDER, ALCOHOLISM AND STRESS DISORDER
#1973ST2-BASED DENGUE FEVER DIAGNOSTIC
#1974Methods for Assaying MC1R Variants and Mitochondrial Markers in Skin Samples
#1975ISOLATED POPULATION OF LUMINAL STEM CELLS THAT GIVE RISE TO PROSTATE CANCER AND METHODS OF USING SAME
#1976Nucleic acid comprising chimeric gene derived from hepatitis C virus
#1977COMPOSITIONS, METHODS AND KITS FOR DETECTING AND TREATING CANCER
#1978COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF HEPATOBILIARY DISEASE AND ASSOCIATED DISORDERS
#1979DIAGNOSTIC MARKER AND PLATFORM FOR DRUG DESIGN IN MYOCARDIAL INFARCTION AND HEART FAILURE
#1980COOPERATING ONCOGENES IN CANCER
#1981Recurrent gene fusions in prostate cancer
#1982MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer
#1983Compositions and methods modulating MG29 for the treatment of diabetes
#1984Proteinic marker for early diagnosis of liver cancer
#1985COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION
#1986HUMAN TRANSCRIPTOMES
#1987Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof
#1988Diagnosis and treatment of autism using CD38
#1989Detection and treatment of schizophrenia
#1990MIPOL1-ETV1 gene rearrangements
#1991Methods and Compositions for Treating Neurological Disease
#1992BRCA1 function-based cellular assays
#1993Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
#1994Method for treating synovial sarcoma
#1995METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
#1996Methods for treating cancer using ephrin type-A receptor 10 antibodies conjugated to cytotoxic agents
#1997MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia (AML) and Uses Thereof
#1998Methods and Compositions Relating to Carcinoma Stem Cells
#1999Methods for assessing efficacy of chemotherapeutic agents
#2000TRPC6 involved in glomerulonephritis
#2001Method of diagnosing mild osteoarthritis
#2002Carboxylesterase-1 Polymorphisms and Methods of Use Therefor
#2003Screening method for damaged DNA repairing substance
#2004Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma
#2005Genetic Variants Contributing to Risk of Prostate Cancer
#2006BREAST TUMOUR GRADING
#2007METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#2008BIOMARKERS FOR PROSTATE CANCER
#2009Markers for breast cancer
#2010Ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cells
#2011METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8
#2012COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING NEUROPSYCHIATRIC DISORDERS
#2013Targets for use in diagnosis, prognosis and therapy of cancer
#2014Diagnostic composition for hepatocellular carcinoma, a diagnostic kit comprising it and diagnostic methods of hepatocellular carcinoma
#2015Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers
#2016Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
#2017Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2
#2018BREAST CANCER EXPRESSION PROFILING
#2019MCAM modulation and uses thereof
#2020KCNN3 AS DIAGNOSTIC AND THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISEASES
#2021Transcription factor decoys, compositions and methods
#2022COMPOSITIONS AND METHODS OF TREATING NEOPLASIA
#2023Methods to increase or decrease bone density
#2024NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 58P1D12 USEFUL IN TREATMENT AND DETECTION OF CANCER
#2025Use of FLJ25416 gene
#2026BIOMARKERS FOR CARDIOVASCULAR DISEASE
#2027Further Use of Protein Kinase N Beta
#2028PATHWAYS INVOLVED IN ARTERIOGENESIS AND USES THEREOF
#2029Gene Expression Profiling for Identification, Monitoring and Treatment of Cervical Cancer
#2030Methods and compositions for diagnosing osteoarthritis in a feline
#2031MicroRNA Expression Profiling and Targeting in Peripheral Blood in Lung Cancer
#2032Method for evaluating or selecting agent for preventing or curing photodamage of skin
#2033Method of examining inflammatory disease and method of screening remedy for inflammatory disease
#2034SLCO1B3 genotype
#2035NOVEL COMPOSITIONS AND METHODS IN CANCER WITH ALTERED EXPRESSION OF KCNJ9
#2036Diagnosis and therapy of cancer using SGP28-related molecules
#2037ACE2 activation for treatment of heart, lung and kidney disease and hypertension
#2038MIR-101 CANCER MARKERS
#2039USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTIC RISK
#2040Identification of cancer protein biomarkers using proteomic techniques
#2041CANCER
#2042ASSAY KIT FOR IN-SITU HYBRIDIZATION OF RHOGDI2 GENE, METHOD THEREFOR AND USE THEREOF THE ASSAY KIT
#2043Lipocalin-2 antibodies for methods of treatment
#2044Ninjurin-1 modulation and uses thereof
#2045PREDICTION OF POTENTIAL DRUG-DRUG INTERACTIONS USING GENE EXPRESSION PROFILING OF DRUG TRANSPORTERS, CYTOCHROME P450S AND NUCLEAR X RECEPTORS
#2046Gene expression profiling of Parkinson's Disease
#2047NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION
#2048Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#2049Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Cancer
#2050EXPRESSION PROFILE OF PROSTATE CANCER
#2051Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
#2052GENETIC PREDICTION OF SCHIZOPHRENIA SUSCEPTIBILITY
#2053EGFR mutations
#2054METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF SCREENING FOR MODULATORS OF PROSTATE CANCER
#2055Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#2056MicroRNA molecules
#2057SOCS-3 promoter methylation in cancer
#2058Method of treatment or prophylaxis of inflammatory pain
#2059Methods for the diagnosis and the prognosis of a brain tumor
#2060GENEMAP OF THE HUMAN ASSOCIATED WITH CROHN'S DISEASE
#2061Methods and compositions for modulating hair growth
#2062NOVEL 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 AND 32222 MOLECULES AND USES THEREFOR
#2063CANCER ASSOCIATED GENE LY6K
#2064NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER
#2065COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION
#2066WNT PATHWAY MUTATIONS IN CANCER STEM CELLS
#2067PTGS2 HAPLOTYPES
#2068Micro-RNAs modulating immunity and inflammation
#2069Identification of novel genes coding for small temporal RNAS
#2070Identification of novel genes coding for small temporal RNAs
#2071Pro-angiogenic genes in ovarian tumor endothelial cell isolates
#2072MICRORNA EXPRESSION PROFILE ASSOCIATED WITH PANCREATIC CANCER
#2073METHOD FOR IDENTIFYING A RENAL FIBROSIS PROCESS USE OF SNAIL- ACTIVITY-INHIBITING COMPOUNDS IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS, METHOD FOR IDENTIFYING SAID INHIBITING COMPOUNDS, SAID PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF
#2074Identification and Characterization of Pregnancy-Associated Genetic Signatures and Use Thereof for Diagnosis and Treatment of Breast Cancer
#2075Diagnostic tool for diagnosing benign versus malignant thyroid lesions
#2076Cardiac Conduction System (CCS) Progenitor Cells and Uses Thereof
#2077Methods and materials related to grey alleles
#2078Gene Expression Profiling for Identification, Monitoring, and Treatment of Lupus Erythematosus
#2079Methods for the Treatment and Diagnosis of Bone Mineral Density Related Diseases
#208015-PGDH in colon cancer
#2081GENES ASSOCIATED WITH CHEMOTHERAPY RESPONSE AND USES THEREOF
#2082METHODS AND KITS FOR DIAGNOSIS AND TREATMENT OF CELL-CELL JUNCTION RELATED DISORDERS
#2083Cyp1B1 Genotype
#2084Methods of screening and compositions for life span modulators
#2085METHODS AND COMPOSITIONS FOR DIAGNOSING BLADDER CANCER
#2086METHODS FOR DETERMINING THE PROGNOSIS FOR PATIENTS WITH A PROSTATE NEOPLASTIC CONDITION
#2087Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis
#2088Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin B and related compounds
#2089Methods and compositions related to arrhythmogenic right ventricular cardiomyopathy (ARVC)
#2090Methods of isolating methylated CpG islands
#2091GENETIC DIAGNOSIS OF DEPRESSION
#2092METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE
#2093Compositions And Methods For Identifying And Treating Subjects At Risk Of Developing Type 2 Diabetes
#2094COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES
#2095TGFBR1 expression modifies risk for colorectal cancer
#2096METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF CARDIOVASCULAR FUNCTION AND DISORDERS
#2097Breast Cancer Susceptibility Gene GT198 and Uses Thereof
#2098PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN
#2099MICRO RNAS AS MARKERS OF THE FUNCTIONAL STATE OF A DENDRITIC CELL
#2100Tumor Suppressor Killin